Medication-Assisted Treatment - Prescription Drug and Opioid Addiction
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract initiative aims to broaden access to medication-assisted treatment for opioid use disorder by increasing the availability of evidence-based therapies and recovery support services. The program seeks to reduce illicit opioid use, prevent prescription opioid misuse, and lower overdose rates through expanded treatment options and improved public health infrastructure. It is managed by the Substance Abuse and Mental Health Services Administration under the Department of Health and Human Services, with the initiative forecasted to be posted on March 20, 2026. Interested applicants can direct inquiries to Fred Bamfo via email at mat-pdoa-c@samhsa.hhs.gov or by phone at 240-276-2423. The opportunity is open to organizations capable of delivering comprehensive care services nationwide, with no specific set-aside or NAICS code designated at this stage. Further application details will be available through the Grants.gov portal upon formal release.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The purpose of this program is to expand access to medications for opioid use disorder, increasing availability of treatment and recovery for individuals with opioid use disorder, and to reduce illicit opioid use and prescription opioid misuse and overdose.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → Substance Abuse And Mental Health Services Administration
Same awarding agency
